BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32808056)

  • 1. Magnetic resonance imaging radiomic analysis can preoperatively predict G1 and G2/3 grades in patients with NF-pNETs.
    Bian Y; Li J; Cao K; Fang X; Jiang H; Ma C; Jin G; Lu J; Wang L
    Abdom Radiol (NY); 2021 Feb; 46(2):667-680. PubMed ID: 32808056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT-Based Radiomics Score for Distinguishing Between Grade 1 and Grade 2 Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Bian Y; Jiang H; Ma C; Wang L; Zheng J; Jin G; Lu J
    AJR Am J Roentgenol; 2020 Oct; 215(4):852-863. PubMed ID: 32755201
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative Prediction of G1 and G2/3 Grades in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors Using Multimodality Imaging.
    Liu C; Bian Y; Meng Y; Liu F; Cao K; Zhang H; Fang X; Li J; Yu J; Feng X; Ma C; Lu J; Xu J; Shao C
    Acad Radiol; 2022 Apr; 29(4):e49-e60. PubMed ID: 34175209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics analysis from magnetic resonance imaging in predicting the grade of nonfunctioning pancreatic neuroendocrine tumors: a multicenter study.
    Zhu HB; Zhu HT; Jiang L; Nie P; Hu J; Tang W; Zhang XY; Li XT; Yao Q; Sun YS
    Eur Radiol; 2024 Jan; 34(1):90-102. PubMed ID: 37552258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncontrast Radiomics Approach for Predicting Grades of Nonfunctional Pancreatic Neuroendocrine Tumors.
    Bian Y; Zhao Z; Jiang H; Fang X; Li J; Cao K; Ma C; Guo S; Wang L; Jin G; Lu J; Xu J
    J Magn Reson Imaging; 2020 Oct; 52(4):1124-1136. PubMed ID: 32343872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images.
    Dong Y; Yang DH; Tian XF; Lou WH; Wang HZ; Chen S; Qiu YJ; Wang W; Dietrich CF
    Br J Radiol; 2023 Sep; 96(1149):20220783. PubMed ID: 37393539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-Radiomic Approach to Predict G1/2 Nonfunctional Pancreatic Neuroendocrine Tumor.
    Zhao Z; Bian Y; Jiang H; Fang X; Li J; Cao K; Ma C; Wang L; Zheng J; Yue X; Zhang H; Wang X; Madabhushi A; Xu J; Jin G; Lu J
    Acad Radiol; 2020 Dec; 27(12):e272-e281. PubMed ID: 32037260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate non-invasive grading of nonfunctional pancreatic neuroendocrine tumors with a CT derived radiomics signature.
    Javed AA; Zhu Z; Kinny-Köster B; Habib JR; Kawamoto S; Hruban RH; Fishman EK; Wolfgang CL; He J; Chu LC
    Diagn Interv Imaging; 2024 Jan; 105(1):33-39. PubMed ID: 37598013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
    Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
    Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative prediction of pancreatic neuroendocrine tumor grade based on
    Ma J; Wang X; Tang M; Zhang C
    Endocrine; 2024 Feb; 83(2):502-510. PubMed ID: 37715934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-based radiomics approach for differentiation of hypovascular non-functional pancreatic neuroendocrine tumors and solid pseudopapillary neoplasms of the pancreas.
    Song T; Zhang QW; Duan SF; Bian Y; Hao Q; Xing PY; Wang TG; Chen LG; Ma C; Lu JP
    BMC Med Imaging; 2021 Feb; 21(1):36. PubMed ID: 33622277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
    Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
    J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging.
    Lotfalizadeh E; Ronot M; Wagner M; Cros J; Couvelard A; Vullierme MP; Allaham W; Hentic O; Ruzniewski P; Vilgrain V
    Eur Radiol; 2017 Apr; 27(4):1748-1759. PubMed ID: 27543074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing pancreatic solid serous cystadenomas from nonfunctional pancreatic neuroendocrine tumors by computed tomography: A propensity score analysis.
    Fang X; Jiang H; Cao K; Li J; Liu F; Wang L; Lu J; Shao C; Bian Y
    Medicine (Baltimore); 2022 Sep; 101(37):e30523. PubMed ID: 36123910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of CT-based radiomics in diagnosis of superior mesenteric vein resection margin in patients with pancreatic head cancer.
    Bian Y; Jiang H; Ma C; Cao K; Fang X; Li J; Wang L; Zheng J; Lu J
    Abdom Radiol (NY); 2020 Mar; 45(3):759-773. PubMed ID: 31932878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors.
    Ye JY; Fang P; Peng ZP; Huang XT; Xie JZ; Yin XY
    Eur Radiol; 2024 Mar; 34(3):1994-2005. PubMed ID: 37658884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.
    Yang DH; Cheng J; Tian XF; Zhang Q; Yu LY; Qiu YJ; Lu XY; Lou WH; Dong Y; Wang WP
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
    Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
    Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grade 2 pancreatic neuroendocrine tumors: overbroad scope of Ki-67 index according to MRI features.
    Hu Y; Rao S; Xu X; Tang Y; Zeng M
    Abdom Radiol (NY); 2018 Nov; 43(11):3016-3024. PubMed ID: 29619528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.